Cargando…

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology

The aim of this systematic review is to present an up-to-date review of available publications investigating the cellular mechanisms initiating the development of medication-related osteonecrosis of the jaw caused by zoledronic acid. Electronic searches of MEDLINE/PubMed and Scopus were conducted on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsalih, Aya, Dam, Annica, Lindberg, Pia, Truedsson, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392270/ https://www.ncbi.nlm.nih.gov/pubmed/34435997 http://dx.doi.org/10.3390/dj9080085

Ejemplares similares

Denosumab/ibandronic acid/zoledronic acid: Medication-related osteonecrosis of jaw: case report
Publicado: (2021)

A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw
por: Bullock, George, et al.
Publicado: (2022)

Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
por: Lundberg, A.P., et al.
Publicado: (2016)

Dental extraction following zoledronate, induces osteonecrosis in rat´s jaw
por: Vidal-Gutiérrez, Ximena, et al.
Publicado: (2017)

Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview
por: Tetradis, Sotirios, et al.
Publicado: (2023)

Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws
por: Sarkarat, Farzin, et al.
Publicado: (2014)

Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
por: Chen, Xin, et al.
Publicado: (2021)

An Approach for the Prevention, Diagnosis, and Treatment of Jaw Osteonecrosis: Report of a Case Associated with Zoledronic Acid
por: de Alexandria Santos, Danila S., et al.
Publicado: (2020)

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid
por: Ciobanu, George Adrian, et al.
Publicado: (2023)

A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma
por: Howie, R. Nicole, et al.
Publicado: (2015)

Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization
por: Biguetti, Claudia Cristina, et al.
Publicado: (2019)

Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis
por: Limones, Alvaro, et al.
Publicado: (2020)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

THU442 A Case Of Early Medication Related Osteonecrosis Of The Jaw In Patient Receiving Intravenous Zoledronate For Treatment Of Osteoporosis
por: Ekpe, Victor, et al.
Publicado: (2023)

Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid
por: Marín-Fernández, Ana-Belén, et al.
Publicado: (2015)

Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review
por: Scribante, Andrea, et al.
Publicado: (2023)

Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis
por: Messer, J.G., et al.
Publicado: (2017)

Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid
por: Ciobanu, George Adrian, et al.
Publicado: (2023)

Uncommon presentation of potential medication-related osteonecrosis of the jaw
por: Kim, Seong-Gon, et al.
Publicado: (2016)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
por: Fusco, Vittorio, et al.
Publicado: (2018)

Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis
por: Messer, Jonathan G., et al.
Publicado: (2019)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
por: Moradi, Saeed, et al.
Publicado: (2023)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

Bisphosphonate Associated Osteonecrosis of the Jaw: An Update on Pathophysiology, Risk Factors, and Treatment
por: Rasmusson, Lars, et al.
Publicado: (2014)

Medication-related osteonecrosis of the jaw: An update
por: Bansal, Hitesh
Publicado: (2022)

Update on Medication Related Osteonecrosis of the Jaws
por: Boyd, Barry C.
Publicado: (2023)

Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?
por: Pilanci, Kezban Nur, et al.
Publicado: (2015)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
por: Cassoni, Andrea, et al.
Publicado: (2016)

Severe Maxillary Medication-related Osteonecrosis of the Jaw
por: Kitajima, Shoichiro, et al.
Publicado: (2018)

Medication-related Osteonecrosis of the Jaw: A Review
por: AlDhalaan, Nouf A, et al.
Publicado: (2020)

Anatomical factors in medication-related osteonecrosis of the jaws
por: Correia, J. A., et al.
Publicado: (2021)

Medication-related osteonecrosis of the jaw: Prosthodontic considerations
por: Ali, Islam E., et al.
Publicado: (2022)

Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
por: Roato, Ilaria, et al.
Publicado: (2023)

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review
por: Kourie, Hampig Raphael, et al.
Publicado: (2015)

Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
por: AlRowis, Raed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_huochfguq2un48eg6j23b5m7al